Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Clinical Epidemiology|March 8, 2021
Adverse event recording failed to reflect potential harms: a review of trial protocols of behavioral, lifestyle and psychological therapy interventionsDiana Papaioannou, Cindy Cooper, Cara Mooney, et al.
Plant Disease|February 14, 2019
Bemisia afer sensu lato, a Vector of Sweet potato chlorotic stunt virusHeidy A Gamarra, Segundo Fuentes, Francisco J Morales, et al.
Scientific Reports|February 7, 2017
Transcriptome sequencing identifies novel persistent viruses in herbicide resistant wild-grassesFederico Sabbadin, Rachel Glover, Rebecca Stafford, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 1, 2020
A P2RX7 single nucleotide polymorphism haplotype promotes exon 7 and 8 skipping and disrupts receptor functionKristen K Skarratt, Ben J Gu, Michael D Lovelace, et al.
Orphanet Journal of Rare Diseases|June 4, 2026
Mesenchymal stromal cell infusions of umbilical cord-derived mesenchymal stromal cells in children with Recessive Dystrophic Epidermolysis Bullosa (MissionEB): a qualitative sub study of a randomised, double-blind, placebo controlled, crossover, phase 3 trialKatie Biggs, Shamila Ditta, Maria L Bageta, et al.
The British Journal of Dermatology|December 18, 2025
O04 Mission EB -mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: a randomised, double-blinded, placebo controlled, crossover trialMaria L Bageta, Pablo López Balboa, Matt Bursnall, et al.
BMJ Open|May 21, 2025
Mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: MissionEB protocol for a randomised, double-blinded, placebo-controlled, two-centre, crossover trial with an internal phase I dose de-escalation phase and open-label extensionMaria L Bageta, Pablo López-Balboa, Munyaradzi Dimairo, et al.
Eclinicalmedicine|November 3, 2025
Mesenchymal stromal cell infusions of umbilical cord-derived mesenchymal stromal cells in children with recessive dystrophic epidermolysis bullosa (MissionEB): a randomised, double-blind, placebo controlled, crossover, phase 3 trial with an internal phase 1 dose de-escalation phaseMaria L Bageta, Pablo Lopez-Balboa, Matt Bursnall, et al.
BMJ Open|February 5, 2024
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trialGavin Brittain, Jennifer Petrie, Kate E M Duffy, et al.
Health Technology Assessment (Winchester, England)|October 19, 2022
Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCTSolomon Tesfaye, Gordon Sloan, Jennifer Petrie, et al.
Pageof 2